Key Changes for PY2024
The changes outlined below are not exhaustive and do not include changes to QHP Application templates or specific data entry requirements. Issuers should refer to the Published Guidance and Regulations webpage and review the most updated version of the QHP Issuer Application Instructions on the QHP certification website.
Network Adequacy Standards
As delineated in the HHS Notice of Benefit and Payment Parameters for 2024, CMS requires that plans across all Exchange types use a network of providers that complies with Sections 45 CFR 156.230 and 45 CFR 156.235. CMS allows for a limited exception to the provider network requirement for SADPs that sell plans in areas where it is prohibitively difficult for the issuer to establish a network of dental providers. Under this exception, an area is considered “prohibitively difficult” for an SADP issuer to establish a network of dental providers based on attestations from State Department of Insurance in states with at least 80% of their counties classified as Counties with Extreme Access Considerations, that at least one of the following factors exists in the area of concern: a significant shortage of dental providers, a significant number of dental providers unwilling to contract with Marketplace issuers, or significant geographic limitations impacting consumer access to dental providers. The exception that these sections do not apply to plans without a provider network is no longer in place. Under this rule, a plan cannot be certified if it does not use a network of providers that complies with network adequacy standards. Refer to the ECP and Network Adequacy webpage for more information.
Essential Community Providers
CMS requires that plans across all Exchange-types must use a network of providers that complies with sections 45 CFR 156.230 and 45 CFR 156.235 of the HHS Notice of Benefit and Payment Parameters for 2024, with the limited exception for certain SADPs described above. The exception that these sections do not apply to plans without a provider network is no longer in place. Under this rule, a plan cannot be certified if it does not use a network of providers that complies with ECP standards. Additionally, CMS requires the application of the 35 percent threshold to two of the major ECP categories: Federally Qualified Health Centers (FQHCs) and Family Planning Providers. Medical QHP issuers need to contract with at least 35 percent of available providers in the plan’s service area for both of these categories; SADP issuers need to contract with at least 35 percent of FQHCs offering dental services in the plan’s service area. These contracts—for both QHPs and SADPs—will also count toward the overall 35 percent threshold, which remains in place. Finally, there are new additions to the ECP provider types and categories. Rural Emergency Hospitals are now a provider type in the Other ECP Providers major ECP category, and there are two new major ECP categories: Substance Use Disorder Treatment Centers and Mental Health Facilities. Refer to the ECP and Network Adequacy webpage for more information.
Standardized Plan Options
There is no longer a standardized plan option for the non-expanded bronze metal level. Additionally, for any standardized plan options that include the zero cost-share preventive drugs and medical service drugs tier types, issuers must adhere to the specified tier types for the associated formulary ID within the Prescription Drug Template. Specifically, within the Prescription Drug Template, for standardized plan options, issuers should enter zero cost preventive drugs for tier one, generic drugs for tier two, preferred brand drugs for tier three, non-preferred drugs for tier four, specialty drugs for tier five, and medical services drugs for tier six, as applicable. Refer to the Plans and Benefits webpage and the Prescription Drugs webpage for more information.
Finally, CMS did not finalize the proposal that would have required issuers to place all covered generic prescription drugs in the generic drug cost-sharing tier and all brand drugs in either the preferred brand or non-preferred brand drug cost-sharing tiers (or the specialty drug cost-sharing tier, with an appropriate and non-discriminatory basis) within these standardized plan options. This means that issuers of these standardized plan options continue to retain the ability to place particular prescription drugs on particular formulary tiers, subject to existing non-discrimination requirements.
Limits to the Number of Non-Standardized Plan Options
CMS will limit the number of non-standardized plan options that QHP issuers can offer through the Exchange (including State-based Exchanges on the Federal Platform) to four non-standardized plan options per product type, metal level (excluding catastrophic plans), inclusion of dental and/or vision benefits, in any service area, for PY2024. Under this requirement, for example, an issuer is limited to offering four gold HMO and four gold PPO non-standardized plan options in the same service area. Refer to the Plans and Benefits webpage for more information.
CMS will then limit the number of non-standardized plan options that QHP issuers can offer through the Exchange (including State-based Exchanges on the Federal Platform) to two non-standardized plan options per product type, metal level (excluding catastrophic plans), inclusion of dental and/or vision benefits, in any service area, for PY2025 and subsequent plan years. CMS also reserved a subparagraph in the regulation text at § 156.202, which it explained that it intends to propose to amend to introduce an exceptions process that would allow issuers to offer non-standardized plan options in excess of this limit for PY2025 and subsequent plan years. CMS noted that this proposal would be subject to notice and comment in the HHS Notice of Benefit and Payment Parameters for 2025 proposed rule.
Federal Hierarchy Modifications
Enrollees in a bronze plan who are eligible for cost-sharing reductions (CSRs) and would otherwise be automatically re-enrolled in a bronze plan without CSRs will instead be automatically re-enrolled in a silver plan in the same product with a lower or equivalent premium provided that certain conditions are met. Additionally, for enrollees whose plans are no longer available to them or are being re-enrolled into a silver plan to receive CSRs, CMS or the state must ensure re-enrollment into plans with the most similar network to their current plan, provided that certain conditions are met. Refer to the HHS Notice of Benefit and Payment Parameters for 2024 and the Plan ID Crosswalk webpage for more information.
Adverse Tiering
CMS will conduct Adverse Tiering reviews for all FFE issuers seeking to offer QHPs. CMS’s review will confirm that QHP enrollees have access to drugs or drug classes needed to treat chronic, high-cost conditions at lower cost tiers. This standard is meant to prevent issuers from placing drugs for these medical conditions only on a high-cost tier, thereby discouraging consumers with these medical conditions from enrolling in those plans. The Adverse Tiering review will consist of the following medical conditions: hepatitis C virus, HIV, multiple sclerosis, and rheumatoid arthritis. Refer to the Prescription Drugs webpage for more information.
Plan Marketing Name Review
Per the HHS Notice of Benefit and Payment Parameters for 2024, issuers’ plan marketing and plan variation marketing names must include only correct information and cannot include misleading or inaccurate material. CMS will review plan and plan variation marketing names for misleading information, inaccurate information, or omission of material fact during the annual QHP certification process. Refer to the Plans and Benefits webpage for more information.
SADP Age on Effective Date Requirement
Per the HHS Notice of Benefit and Payment Parameters for 2024, SADP issuers are required to use an enrollee’s age at the time of policy issuance or renewal (referred to as age on effective date) as the sole method to calculate an enrollee’s age for rating and eligibility purposes. This requirement is a condition of QHP certification, beginning with Exchange certification for PY2024. This requirement also extends to all Exchange-certified SADPs, whether they are sold on- or off-Exchange. Refer to the Business Rules webpage for more information.
SADP Guaranteed Rates Requirement
Per the HHS Notice of Benefit and Payment Parameters for 2024, SADP issuers are required to submit guaranteed rates as a condition of QHP certification, beginning with Exchange certification for PY2024. This requirement extends to all Exchange-certified SADPs, whether they are sold on- or off-Exchange. This change will help reduce the risk of incorrect advance premium tax credit (APTC) calculation for the pediatric dental EHB portion of premiums, thereby reducing the risk of consumer harm. Refer to the Plans and Benefits webpage and Rates webpage for more information.
New HIOS Module for Application Submission
The HIOS Marketplace Plan Management System (MPMS) Module is a new module where FFE issuers, who previously submitted QHP Application data in the Issuer, Benefits & Service Area, and Rating Modules, will submit their QHP Application. All issuers, including issuers in states performing plan management functions and SBE-FP states, will also submit their interoperability and URL data within this module. All issuers will also access the Plan Validation Workspace within this module in order to validate plan data prior to submission. Issuers in states performing plan management functions and SBE-FPs will continue to submit the majority of their QHP Application data through SERFF. Refer to the Submission Systems webpage and Application Submission webpage for more information.
Pre-Submission Data Validation
Issuers must validate their QHP Application for compliance with several federal standards prior to submitting these data to CMS (via HIOS) or their state (via SERFF). All issuers are required to use the Plan Validation Workspace within the HIOS MPMS Module to access validation errors and warnings in their QHP Application data. Issuers must resolve all identified validation errors prior to submitting their QHP Application(s) to CMS (via HIOS) or to their state (via SERFF). SERFF Validate & Transform has also been enhanced to include checks for these standards and issuers in states performing plan management functions and SBE-FPs will not be able to submit data to their state in SERFF until they have passed these validations through SERFF Validate & Transform. Refer to the MPMS Module User Guide and the Data Validation webpage for more information.